论文信息 - Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV - 字舞流文

Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV

M. Yuen | S. Yoon | H. Chung | C. Lai | P. Hsyu | Hosu Kim | Hae Rim Kim | D. Averett | K. Han | C. R. Kim | J.Y. Kim | Sh Um